Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.411EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.217EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.17 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.527EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.500EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.147EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.487EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.121EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.115EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.127.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.88EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.289EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.365EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.252EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.223EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.640.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.11 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.355EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.34.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.71 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.33.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.465EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
S.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.215EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.82EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.462EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.218EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBNEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used